Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 15, 2023
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
Tue, March 14, 2023
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
Itay Michaeli Maintained (AMLX) at Strong Buy with Increased Target to $54 on, Mar 14th, 2023
Itay Michaeli of Citigroup, Maintained "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy with Increased Target from $51 to $54 on, Mar 14th, 2023.
Itay has made no other calls on AMLX in the last 4 months.
There is 1 other peer that has a rating on AMLX. Out of the 1 peers that are also analyzing AMLX, 0 agree with Itay's Rating of Hold.
This is the rating of the analyst that currently disagrees with Itay
- Geoff Meacham of "B of A Securities" Initiated at Strong Buy and Held Target at $50 on, Thursday, January 5th, 2023
